About Madison Vaccines
Madison Vaccines is a company based in Madison (United States) founded in 2012 by Richard Lesniewski.. Madison Vaccines has raised $18 million across 4 funding rounds from investors including Venture Investors, WARF and Venture Management. Madison Vaccines offers products and services including Immunotherapies and Clinical Trials. Madison Vaccines operates in a competitive market with competitors including Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nymox Pharmaceutical and Nuage Therapeutics, among others.
- Headquarter Madison, United States
- Founders Richard Lesniewski
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Madison Vaccines, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18 M (USD)
in 4 rounds
-
Latest Funding Round
$2 M (USD), Series A
Mar 10, 2015
-
Investors
Venture Investors
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Madison Vaccines
Madison Vaccines offers a comprehensive portfolio of products and services, including Immunotherapies and Clinical Trials. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops immune-based treatments to combat prostate cancer progression.
Conducts trials for testing combination therapies in oncology.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Madison Vaccines
Madison Vaccines has successfully raised a total of $18M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $2 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $2.0M
-
First Round
First Round
(13 Jan 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Series A - Madison Vaccines | Valuation |
investors |
|
| Oct, 2014 | Amount | Grant - Madison Vaccines | Valuation |
investors |
|
| Jan, 2014 | Amount | Series A - Madison Vaccines | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Madison Vaccines
Madison Vaccines has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Venture Investors, WARF and Venture Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Founded Year | Domain | Location | |
|
Research innovations are supported and commercialized by WARF.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Madison Vaccines
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Madison Vaccines
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Madison Vaccines Comparisons
Competitors of Madison Vaccines
Madison Vaccines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nymox Pharmaceutical and Nuage Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Peptide-targeted radiopharmaceuticals for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Develops small molecule based drug for multiple disease treatment
|
|
| domain | founded_year | HQ Location |
Cancer therapeutics are developed using dual-targeted radionuclide therapy.
|
|
| domain | founded_year | HQ Location |
Provides research and development of novel drugs and diagnostic products for the aging population
|
|
| domain | founded_year | HQ Location |
Drugs are developed for intrinsically disordered protein targets.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Madison Vaccines
Frequently Asked Questions about Madison Vaccines
When was Madison Vaccines founded?
Madison Vaccines was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Madison Vaccines located?
Madison Vaccines is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Who is the current CEO of Madison Vaccines?
Richard Lesniewski is the current CEO of Madison Vaccines. They have also founded this company.
Is Madison Vaccines a funded company?
Madison Vaccines is a funded company, having raised a total of $18M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8M, raised on Jan 13, 2014.
What does Madison Vaccines do?
Madison Vaccines was founded in 2012 in Madison, United States, within the biotechnology sector. Immunotherapies targeting prostate cancer in patients are developed by the company. Plasmid DNA is combined with immune suppression inhibitors, including anti-PD-1, to form these treatments. Operations focus on advancing such therapies for clinical application in oncology.
Who are the top competitors of Madison Vaccines?
Madison Vaccines's top competitors include Radionetics, Nuage Therapeutics and Convergent Therapeutics.
What products or services does Madison Vaccines offer?
Madison Vaccines offers Immunotherapies and Clinical Trials.
Who are Madison Vaccines's investors?
Madison Vaccines has 5 investors. Key investors include Venture Investors, WARF, Venture Management, SWIB (State of Wisconsin Investment Board), and Prostate Cancer Foundation.